Abstract:MicroRNAs (miRNAs) act as important gene regulators in human genomes and their aberrant expression links to many malignancies. We previously identified a different characteristic miRNA expression profile in cervical cancer from that in cervical normal tissues, including the downregulated miR-424. However, the role and mechanism of miR-424 in cervical cancer still remain unknown. Here, we focused on identifying the tumor-suppressive function and clinical significance of miR-424 and exploring the mechanistic relevance by characterizing its target. We showed a significantly decreased expression of miR-424 in 147 cervical cancer tissues versus 74 cervical normal tissues by performing quantitative RT–PCR. In 147 cervical cancer tissue samples, low-level expression of miR-424 was positively correlated with poor tumor differentiation, advanced clinical stage, lymph node metastasis and other poor prognostic clinicopathological parameters. Further in vitro observations showed that enforced expression of miR-424 inhibited cell growth by both enhancing apoptosis and blocking G1/S transition, and suppressed cell migration and invasion in two human cervical cancer cell lines, SiHa and CaSki, implying that miR-424 functions as a tumor suppressor in the progression of cervical cancer. Interestingly, overexpression of miR-424 inhibited the expression of protein checkpoint kinase 1 (Chk1) and phosphorylated Chk1 (p-Chk1) at residues Ser345 and decreased the activity of luciferase-reporter containing the 3′-untranslated region (UTR) of Chk1 with predicted miR-424-binding site. Moreover, miR-424 expression levels were inversely correlated with Chk1 and p-Chk1 protein levels in both cervical cancer and normal tissues. Furthermore, RNAi-mediated knockdown of Chk1 decreased matrix metalloproteinase 9 expression and phenocopied the tumor suppressive effects of miR-424 in cell models. Taken together, our results identify a crucial tumor suppressive role of miR-424 in the progression of cervical cancer at least partly via upreglating the expression of Chk1 and p-Chk1, and suggest that miR-424 might be a candidate of prognostic predictor or an anticancer therapeutic target for cervical cancer patients.

Progress of Research in Mir-218 and Cervical Cancer

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

The roles and clinical significance of microRNAs in cervical cancer.

Dysregulated microRNAs involved in the progression of cervical neoplasm

Suppressed Mir-424 Expression Via Upregulation of Target Gene Chk1 Contributes to the Progression of Cervical Cancer

MiR-218 Mediates Tumorigenesis and Metastasis: Perspectives and Implications.

Mir-182 Induces Cervical Cancer Cell Apoptosis Through Inhibiting the Expression of DNMT3a.

MicroRNA-183 in Cancer Progression

Regulatory Mechanism of Mir-20A-5p Expression in Cancer

Mirna-214: Expression, Therapeutic and Diagnostic Potential in Cancer

Mir-141-5p Affects the Cell Proliferation and Apoptosis by Targeting BTG1 in Cervical Cancer

Effect of Mir-212 Targeting TCF7L2 on the Proliferation and Metastasis of Cervical Cancer.

Effect of Mirna-203 on Cervical Cancer Cells and Its Underlying Mechanism.

Mir-187 Overexpression Inhibits Cervical Cancer Progression by Targeting Hpv16 E6

Progress in Studies on the Mechanism of Microrna-218 Expression in Gastric Cancer

MicroRNA and Cervical Cancer

Research Progress on Lung Cancer Related MicroRNAs

Mir-187 Inhibits the Growth of Cervical Cancer Cells by Targeting FGF9

Mir-218 Promoted the Apoptosis of Human Ovarian Carcinoma Cells Via Suppression of the WNT/β-catenin Signaling Pathway

MicroRNA-218 Enhances the Radiosensitivity of Human Cervical Cancer Via Promoting Radiation Induced Apoptosis.

[Recent Progress on Mirnas in the Pathogenesis of Colon Cancer].